You are here

  • Home
  • Archive
  • Volume 71, Issue 3
  • Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration

Citation Tools

Article menu
Download PDFPDF
Clinical and epidemiological research
Concise Report
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Chatzidionysiou K, Lie E, Nasonov E, et al
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration
Annals of the Rheumatic Diseases 2012;71:374-377.